Bora Sever, MD

Dr. Bora Sever has more than 18 year of experience in all aspects of the clinical development cycle. He has conducted more than 200 compliance audits spanning all aspects of pharmacovigilance and risk management, including corrective action planning, documentation reviews, Good Clinical Practice, and business due diligence in support of M&A activities.

Role of Remote Auditing in Maintaining Effective Pharmacovigilance System Oversight
Thursday, December 04, 2014
Over the last decade, there have been significant changes in the legislation governing the development of pharmaceutical and biologic products—many of these aimed at improving patient safety. A number of these changes have focused on developing, ...